Seventh Sense Biosystems has obtained $1.9 million in a round of debt funding from five unnamed investors. Last summer, the Cambridge, Mass.-based startup also raised $10 million in a Series A round that it said would finance the development and commercialization of its Touch Activated Phlebotomy device, its first blood collection product.

Related Summaries